Genome-wide transcriptomics leads to the identification of deregulated genes after deferasirox therapy in low-risk MDS patients

The Pharmacogenomics Journal, Published online: 04 February 2020; doi:10.1038/s41397-020-0154-5Genome-wide transcriptomics leads to the identification of deregulated genes after deferasirox therapy in low-risk MDS patients
Source: The Pharmacogenomics Journal - Category: Drugs & Pharmacology Authors: Source Type: research